Literature DB >> 15884109

YMDD variants of HBV DNA polymerase gene: rapid detection and clinicopathological analysis with long-term lamivudine therapy after liver transplantation.

Fei Pei1, Jun-Yu Ning, Jiang-Feng You, Jing-Pin Yang, Jie Zheng.   

Abstract

AIM: To look for a rapid low-cost technique for the detection of HBV variants.
METHODS: Two patients who underwent orthotopic liver transplantation (OLT) for HBV infection were treated with lamivudine (100 mg daily) and HBV infection recurred in the grafted livers. The patients were monitored intensively for liver enzymes, hepatitis B surface antigen (HBsAg) and HBV DNA in serum. Liver biopsy was performed regularly. HBV DNA in a conserved polymerase domain (the YMDD locus) was amplified from serum of each patient by PCR and sequenced. HBV genotypes were analyzed by restriction fragment length polymorphism (RFLP) of the PCR products generated from a fragment of the polymerase gene.
RESULTS: YMDD wild-type HBV was detected in one patient by PCR-RFLP and DNA sequencing 19 mo after OLT, and YIDD mutant-type HBV in the other patient, 16 mo after OLT.
CONCLUSION: PCR-RFLP assay is an accurate and simple method for genotyping lamivudine-resistant HBV variants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15884109      PMCID: PMC4305903          DOI: 10.3748/wjg.v11.i18.2714

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.

Authors:  Man-Fung Yuen; Takanobu Kato; Masashi Mizokami; Annie On-On Chan; John Chi-Hang Yuen; He-Jun Yuan; Danny Ka-Ho Wong; Siu-Man Sum; Irene Oi-Lin Ng; Sheung-Tat Fan; Ching-Lung Lai
Journal:  J Hepatol       Date:  2003-11       Impact factor: 25.083

2.  A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.

Authors:  R J Fontana; H W Hann; T Wright; G Everson; A Baker; E R Schiff; C Riely; G Anschuetz; M Riker-Hopkins; N Brown
Journal:  Liver Transpl       Date:  2001-06       Impact factor: 5.799

3.  Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.

Authors:  F Nevens; J Main; P Honkoop; D L Tyrrell; J Barber; M T Sullivan; J Fevery; R A De Man; H C Thomas
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

Review 4.  Management of viral hepatitis B.

Authors:  Chutima Pramoolsinsup
Journal:  J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 4.029

5.  Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.

Authors:  Z Ben-Ari; E Mor; Z Shapira; R Tur-Kaspa
Journal:  Liver Transpl       Date:  2001-02       Impact factor: 5.799

6.  Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.

Authors:  D K Wong; A M Cheung; K O'Rourke; C D Naylor; A S Detsky; J Heathcote
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

Review 7.  Treatment of hepatitis B reinfection after liver transplantation.

Authors:  S Beckebaum; V R Cicinnati; G Gerken; C E Broelsch
Journal:  Minerva Chir       Date:  2003-10       Impact factor: 1.000

8.  Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.

Authors:  D Seehofer; N Rayes; T Steinmüller; A R Müller; S Jonas; U Settmacher; R Neuhaus; T Berg; P Neuhaus
Journal:  Z Gastroenterol       Date:  2002-09       Impact factor: 2.000

9.  Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.

Authors:  Robert Perrillo; Hie-Won Hann; David Mutimer; Bernard Willems; Nancy Leung; William M Lee; Alison Moorat; Stephen Gardner; Mary Woessner; Eric Bourne; Carol L Brosgart; Eugene Schiff
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

Review 10.  Antiviral therapy for chronic hepatitis B: a review.

Authors:  Kazuhiro Hanazaki
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2004-03
View more
  4 in total

1.  Clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B viral infection.

Authors:  Fei Pei; Kewei Shang; Bin Jiang; Hua Wang; Fang Mei; Yan Zhang; Juan Du; Haohao Zhong; Jiangfeng You
Journal:  Hepatol Int       Date:  2013-02-07       Impact factor: 6.047

2.  Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection.

Authors:  Freshte Ghandehari; Abasali Pourazar; Mehrnaz Shanehsaz Zadeh; Nahid Tajedin
Journal:  Asian J Transfus Sci       Date:  2011-01

3.  Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies.

Authors:  Murat Sayan; Sila Cetin Akhan; Omer Senturk
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

4.  Molecular diagnosis of entecavir resistance.

Authors:  Murat Sayan
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.